Merck KGaA (OTCMKTS:MKGAF) Hits New 12-Month Low – Here’s What Happened

Merck KGaA (OTCMKTS:MKGAF) reached a new 52-week low during trading on Thursday . The company traded as low as $142.05 and last traded at $142.05, with a volume of 228 shares changing hands. The stock had previously closed at $145.80.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group raised Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Stock Down 2.6 %

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business’s fifty day moving average price is $157.53 and its 200 day moving average price is $171.18. The firm has a market capitalization of $18.36 billion, a PE ratio of 21.69 and a beta of 0.96.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.